RUBRA MEDICAMENTS LTD. - 531099 - Outcome Of Board Meeting
Outcome of Board meeting04-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Reg 7(3) - Compliance Certificate - March 31, 2020
Reg 7(3) - Compliance certificate - March 31, 202004-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Certificate Under Regulation 40 Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended March 31, 2020
Certificate under Regulation 40 of the SEBI (LODR) Regulations, 2015 for the half year ended March 31, 202002-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- Chief Financial Officer02-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Unaudited Financial Result For The Quarter Ended June 30, 2020 Alongwith Limited Review Report
Unaudited financial Result for the quarter ended June 30, 2020 alongwith Limited Review Report01-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for Intimation Of Board Meeting Dated August 31, 2020
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2020 ,inter alia, to consider and approve Intimation of Board Meeting dated August 31, 202001-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Shareholding for the Period Ended June 30, 2020
Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here01-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Shareholding for the Period Ended March 31, 2020
Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here01-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - DISCLOSURE ON RELATED PARTY TRANSACTIONS FOR THE YEAR ENDED MARCH 31, 2020
DISCLOSURE ON RELATED PARTY TRANSACTIONS FOR THE YEAR ENDED MARCH 31, 202001-09-2020
RUBRA MEDICAMENTS LTD. - 531099 - Financial Result For Year Ended March 31, 2020
Financial Result for year ended March 31, 202031-08-2020